Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study.

Adv Sci (Weinh) · 2026 · PMC13042562 · PMID 41556438

Europe PMC DOI

hedged sentence

0.1590

closest p · 3.2× alpha

0.1590

boldest claim

The sentences

did not reach statistical significancep = 0.159not close (p > 0.1)

Complementary meta‐analytic assessment across institutions revealed moderate heterogeneity (I 2 = 46.5%), though this did not reach statistical significance (Cochran's Q‐test p = 0.159).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.